Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06247072 · ClinicalTrials.gov registry record
TRK-3 Conformance to Standards for Tonometers
A clinical trial, sponsored by Topcon Corporation.
- Completed
- Registry status
- 125
- Enrollment target
NCT06247072: Completed study, sponsored by Topcon Corporation.
NCT06247072 is a clinical trial that has completed, run by Topcon Corporation. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06247072 has completed, sponsored by Topcon Corporation.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
To collect measurements of a new tonometer and show conformance to standards for tonometers.
Primary Outcome
pressure inside the eye
Interventions
- DEVICE Tonometer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2024-02-02 |
| Est. Completion | 2024-04-04 |
What the finished NCT06247072 record still lists
NCT06247072 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Tonometer is the first listed.
NCT06247072 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06247072 about?
NCT06247072 is a clinical study titled "TRK-3 Conformance to Standards for Tonometers". To collect measurements of a new tonometer and show conformance to standards for tonometers.
What is the current status of trial NCT06247072?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2024-02-02. Estimated completion is 2024-04-04.
What interventions are being tested in trial NCT06247072?
The interventions under investigation include: Tonometer (DEVICE).
Who is sponsoring clinical trial NCT06247072?
This trial is sponsored by Topcon Corporation, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI